SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001493152-22-021934
Filing Date
2022-08-11
Accepted
2022-08-10 17:49:15
Documents
2
Group Members
3E BIOVENTURES GP GP, LLC3E BIOVENTURES GP, L.P.QIANYE KAREN LIU

Document Format Files

Seq Description Document Type Size
1 formsc13g.htm SC 13G 150566
2 ex99-1.htm EX-99.1 19352
  Complete submission text file 0001493152-22-021934.txt   171721
Mailing Address 75 SHOREWAY ROAD, SUITE C SAN CARLOS CA 94070
Business Address 75 SHOREWAY ROAD, SUITE C SAN CARLOS CA 94070 650.931.6236
Apexigen, Inc. (Subject) CIK: 0001814140 (see all company filings)

IRS No.: 851260244 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92133 | Film No.: 221152955
SIC: 2834 Pharmaceutical Preparations

Mailing Address SUITE 701 TOWER C TSINGHUA SCIENCE PARK NO. 1 ZHONGGUANCUN EAST ROAD, HAIDIAN BEIJING F4 100084
Business Address SUITE 701 TOWER C TSINGHUA SCIENCE PARK NO. 1 ZHONGGUANCUN EAST ROAD, HAIDIAN BEIJING F4 100084 8613811460182
3E Bioventures Capital, L.P. (Filed by) CIK: 0001911673 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G